- 专利标题： GENETICALLY-ENGINEERED DRUG RESISTANT T CELLS AND METHODS OF USING THE SAME
-
申请号： EP16843195.5申请日： 2016-09-06
-
公开(公告)号： EP3344760A1公开(公告)日： 2018-07-11
- 发明人: LAMB, Lawrence S. , SPENCER, H. Trent , GILLESPIE, G. Yancey
- 申请人： The UAB Research Foundation , Emory University , Children's Healthcare Of Atlanta, Inc.
- 申请人地址： 1720 2nd Avenue South Administration Building 770 Birmingham, AL 35294-0107 US
- 专利权人： The UAB Research Foundation,Emory University,Children's Healthcare Of Atlanta, Inc.
- 当前专利权人： The UAB Research Foundation,Emory University,Children's Healthcare Of Atlanta, Inc.
- 当前专利权人地址： 1720 2nd Avenue South Administration Building 770 Birmingham, AL 35294-0107 US
- 代理机构： Tombling, Adrian George
- 优先权： US201562214071P 20150903
- 国际公布： WO2017041106 20170309
- 主分类号： C12N5/22
- IPC分类号： C12N5/22 ; C12N5/0783 ; C07K14/705 ; A61K35/17 ; A61K31/495 ; A61K39/00
摘要：
The present disclosure provides novel cell compositions engineered to express at least a chimeric antigen receptor and a survival factor. Methods of using such cell compositions are also described.
公开/授权文献
信息查询
